Role of glutathione in the biliary excretion of the arsenical drugs trimelarsan and melarsoprol

This publication has 22 references indexed in Scilit:

• Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
  New England Journal of Medicine, 1998
• Comparative Activity of Melarsoprol and Arsenic Trioxide in Chronic B-Cell Leukemia Lines
  Blood, 1997
• In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
  Blood, 1996
• Pharmacokinetic Properties of the Trypanocidal Drug Melarsoprol
  Chemotherapy, 1993
• Increased biliary excretion of glutathione is generated by the glutathione-dependent hepatobiliary transport of antimony and bismuth
  Biochemical Pharmacology, 1992
• Glutathione-dependent biliary excretion of arsenic
  Biochemical Pharmacology, 1991
• Effect of arsenicals on biliary excretion of endogenous glutathione and xenobiotics with glutathione-dependent hepatobiliary transport
  Biochemical Pharmacology, 1991
• Future prospects for the chemotherapy of human trypanosomiasis
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990
• [9] Depletion of glutathione by inhibition of biosynthesis
  1981
• [8] Chemical depletion of glutathione in vivo
  1981